These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17439247)

  • 1. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380.
    Corradi HR; Chitapi I; Sewell BT; Georgiadis D; Dive V; Sturrock ED; Acharya KR
    Biochemistry; 2007 May; 46(18):5473-8. PubMed ID: 17439247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme.
    Masuyer G; Akif M; Czarny B; Beau F; Schwager SL; Sturrock ED; Isaac RE; Dive V; Acharya KR
    FEBS J; 2014 Feb; 281(3):943-56. PubMed ID: 24289879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme.
    Kröger WL; Douglas RG; O'Neill HG; Dive V; Sturrock ED
    Biochemistry; 2009 Sep; 48(35):8405-12. PubMed ID: 19658433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of angiotensin converting enzyme mutations on the kinetics and dynamics of N-domain selective inhibition.
    Lubbe L; Sewell BT; Sturrock ED
    FEBS J; 2016 Nov; 283(21):3941-3961. PubMed ID: 27636235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Structural Biology of ACE and Development of Domain Selective ACE-inhibitors.
    Polakovičová M; Jampílek J
    Med Chem; 2019; 15(6):574-587. PubMed ID: 31084594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.
    Akif M; Schwager SL; Anthony CS; Czarny B; Beau F; Dive V; Sturrock ED; Acharya KR
    Biochem J; 2011 May; 436(1):53-9. PubMed ID: 21352096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.
    van Esch JH; Tom B; Dive V; Batenburg WW; Georgiadis D; Yiotakis A; van Gool JM; de Bruijn RJ; de Vries R; Danser AH
    Hypertension; 2005 Jan; 45(1):120-5. PubMed ID: 15583077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the C-domain-selective angiotensin-converting enzyme inhibition by bradykinin-potentiating peptide b (BPPb).
    Sturrock ED; Lubbe L; Cozier GE; Schwager SLU; Arowolo AT; Arendse LB; Belcher E; Acharya KR
    Biochem J; 2019 May; 476(10):1553-1570. PubMed ID: 31072910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407.
    Anthony CS; Corradi HR; Schwager SL; Redelinghuys P; Georgiadis D; Dive V; Acharya KR; Sturrock ED
    J Biol Chem; 2010 Nov; 285(46):35685-93. PubMed ID: 20826823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
    Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
    J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
    Ehlers MR; Riordan JF
    Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
    Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
    Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE-domain selectivity extends beyond direct interacting residues at the active site.
    Cozier GE; Lubbe L; Sturrock ED; Acharya KR
    Biochem J; 2020 Apr; 477(7):1241-1259. PubMed ID: 32195541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of angiotensin I-converting enzyme in complex with a selenium analogue of captopril.
    Akif M; Masuyer G; Schwager SL; Bhuyan BJ; Mugesh G; Isaac RE; Sturrock ED; Acharya KR
    FEBS J; 2011 Oct; 278(19):3644-50. PubMed ID: 21810173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin converting enzyme domain structure and properties].
    Kugaevskaia EV
    Biomed Khim; 2005; 51(6):567-80. PubMed ID: 16521820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.
    Watermeyer JM; Kröger WL; O'Neill HG; Sewell BT; Sturrock ED
    Biochem J; 2010 Apr; 428(1):67-74. PubMed ID: 20233165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.